CD&R, McKesson agree to buy Option Care Health for $32.05 a share
Bitget2026/10/06 12:03CD&R, McKesson to acquire Option Care Health for USD 32.05 per share, valuing the business at about USD 5.8 billion. CD&R to hold about 51% at closing; McKesson to invest about USD 1.4 billion for about 49%. Deal includes a framework for McKesson to buy CD&R’s stake later, subject to specified conditions. Price implies about a 37% premium to the stock’s Oct. 5, 2026 close; closing targeted in H1 2027. Shares to be delisted from Nasdaq on completion; the company to operate as a privately held business. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Option Care Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610060800BIZWIRE_USPR_____20261005_BW837505) on October 06, 2026, and is solely responsible for the information contained therein.
- CD&R, McKesson to acquire Option Care Health for USD 32.05 per share, valuing the business at about USD 5.8 billion.
- CD&R to hold about 51% at closing; McKesson to invest about USD 1.4 billion for about 49%.
- Deal includes a framework for McKesson to buy CD&R’s stake later, subject to specified conditions.
- Price implies about a 37% premium to the stock’s Oct. 5, 2026 close; closing targeted in H1 2027.
- Shares to be delisted from Nasdaq on completion; the company to operate as a privately held business.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Crypto prices
More
